First-in-human Phase I Trial of the Bispecific CD47 Inhibitor and CD40 Agonist Fc-fusion Protein, SL-172154 in Patients with Platinum-Resistant Ovarian Cancer
JOURNAL FOR IMMUNOTHERAPY OF CANCER(2025)
关键词
Immunotherapy,Pharmacodynamics - PD,Pharmacokinetics - PK
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要